GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sibannac Inc (OTCPK:SNNC) » Definitions » Revenue

Sibannac (Sibannac) Revenue : $-0.29 Mil (TTM As of Feb. 2017)


View and export this data going back to 2013. Start your Free Trial

What is Sibannac Revenue?

Sibannac's revenue for the three months ended in Feb. 2017 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Feb. 2017 was $-0.29 Mil. Sibannac's Revenue per Share for the three months ended in Feb. 2017 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2017 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Sibannac Revenue Historical Data

The historical data trend for Sibannac's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sibannac Revenue Chart

Sibannac Annual Data
Trend Aug11 Aug12 Aug13 Aug14 Aug15 Aug16
Revenue
Get a 7-Day Free Trial 0.29 0.21 - - -

Sibannac Quarterly Data
May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.09 -0.42 0.04 -

Competitive Comparison of Sibannac's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Sibannac's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sibannac's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sibannac's Revenue distribution charts can be found below:

* The bar in red indicates where Sibannac's Revenue falls into.



Sibannac Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Feb. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sibannac  (OTCPK:SNNC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Sibannac Revenue Related Terms

Thank you for viewing the detailed overview of Sibannac's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sibannac (Sibannac) Business Description

Traded in Other Exchanges
N/A
Address
9535 E. Doubletree Ranch Road, Ste 120, Scottsdale, AZ, USA, 85258
Sibannac Inc is a cannabis research and development company. Its product portfolio includes Hemp oil and Peppermint CBD Mints. The company currently manufactures its CBD products in its new facility in Scottsdale, Arizona.

Sibannac (Sibannac) Headlines

From GuruFocus